We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$553M
AUM Growth
+$21.4M
Cap. Flow
-$13.5M
Cap. Flow %
-2.43%
Top 10 Hldgs %
23.35%
Holding
124
New
1
Increased
20
Reduced
85
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$330K
2
CVGW
Calavo Growers
CVGW
+$265K
3
LH icon
Labcorp
LH
+$226K
4
BUD icon
AB InBev
BUD
+$181K
5
SLB icon
SLB Ltd
SLB
+$180K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.58M
2
GE icon
GE Aerospace
GE
+$1.54M
3
BA icon
Boeing
BA
+$1.17M
4
META icon
Meta Platforms (Facebook)
META
+$865K
5
AAPL icon
Apple
AAPL
+$783K

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 15.63%
3 Industrials 12.54%
4 Communication Services 12.1%
5 Consumer Staples 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
101
Lowe's Companies
LOW
$117B
$307K 0.06%
3,305
– –
CVGW
102
DELISTED
Calavo Growers
CVGW
$303K 0.05%
+3,598
New +$265K
NVS icon
103
Novartis
NVS
$297B
$291K 0.05%
3,878
– –
MAS icon
104
Masco
MAS
$14.1B
$284K 0.05%
6,475
– –
CAG icon
105
Conagra Brands
CAG
$6.94B
$281K 0.05%
7,460
-140
-2% -$4.97K
RTN
106
DELISTED
Raytheon Company
RTN
$281K 0.05%
750
– –
HBAN icon
107
Huntington Bancshares
HBAN
$34.4B
$267K 0.05%
18,400
– –
JNJ icon
108
Johnson & Johnson
JNJ
$618B
$267K 0.05%
2,501
-320
-11% -$44.6K
GAM
109
General American Investors Company
GAM
$1.56B
$258K 0.05%
7,516
– –
MON
110
DELISTED
Monsanto Co
MON
$251K 0.05%
2,152
– –
TXN icon
111
Texas Instruments
TXN
$252B
$246K 0.04%
2,356
– –
JPM icon
112
JPMorgan Chase
JPM
$935B
$241K 0.04%
4,890
– –
LMT icon
113
Lockheed Martin
LMT
$134B
$240K 0.04%
748
– –
HPE icon
114
Hewlett Packard
HPE
$63.4B
$231K 0.04%
16,135
-1,765
-10% -$25.1K
ADSK icon
115
Autodesk
ADSK
$49.5B
$229K 0.04%
2,192
– –
MET icon
116
MetLife
MET
$61.9B
– –
-3,880
Closed -$201K
PCG icon
117
PG&E
PCG
$38.3B
– –
-5,100
Closed -$347K
1 2 3 4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs & Co held 124 positions worth $553M, up 4% from $532M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 2.4%. Jacobs & Co opened 1 new position and exited 2, leaving the 124-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2017 buy was Calavo Growers: 3,598 shares worth $303K.
  • Jacobs & Co added most to Celgene Corp in Q4 2017, an estimated $330K increase.
  • Jacobs & Co's biggest Q4 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.58M.
  • Jacobs & Co fully exited PG&E in Q4 2017, selling an estimated $347K.
  • Jacobs & Co's ten largest holdings make up 23% of its $553M portfolio in Q4 2017.
  • Jacobs & Co opened 1 new position and closed 2 in Q4 2017.
  • Jacobs & Co's portfolio value rose 4% quarter-over-quarter to $553M.

Based on Jacobs & Co's 13F filing for Q4 2017, filed 9 Feb 2018.